François Ghiringhelli (Francois Ghiringhelli)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 63

Top Topics

Locally Advanced

Dna Methylation

Helicobacter Pylori Infection

Top Venues

International journal of molecular sciences

Journal for immunotherapy of cancer

Journal of imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Loïs Coënon, Mannon Geindreau, François Ghiringhelli, Martín Villalba, Mélanie Bruchard
Natural Killer cells at the frontline in the fight against cancer. Cell death & disease 15 (8) (2024)
Brian Belmontes, Katherine K Slemmons, Chun Su, Siyuan Liu, Antonia N Policheni, Jodi Moriguchi, Hong Tan, Fang Xie, Daniel Andrew Aiello, Yajing Yang, Raul Lazaro, Famke Aeffner, Matthew G Rees, Melissa A Ronan, Jennifer A Roth, Mikkel Vestergaard, Sanne Cowland, Jan Andersson, Ian Sarvary, Qing Chen, Pooja Sharma, Patricia Lopez, Nuria A Tamayo, Liping H Pettus, Sudipa Ghimire-Rijal, Susmith Mukund, Jennifer R Allen, Jason DeVoss, Angela Coxon, Jordi Rodon Ahnert, François Ghiringhelli, Nicolas Penel, Hans Prenen, Sanne Glad, Chen-Hua Chuang, Kiana Keyvanjah, Danielle M Townsley, John R Butler, Matthew P Bourbeau, Sean Caenepeel, Paul E Hughes
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients With MTAP-Deleted Cancers. Cancer discovery (2024)
Morgane Peroz, Hugo Mananet, Nicolas Roussot, Courèche Guillaume Kaderbhai, Valentin Derangère, Caroline Truntzer, François Ghiringhelli
Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer. Cancers 16 (17) (2024)
Meriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu, Mayra Ponce, Caroline Truntzer, Romain Boidot, Clément Le Bescop, Thomas Loppinet, Tanguy Corbel, Céline Féger, Karine Bertrand, Arielle Elkrief, Morten Isaksen, Fabien Vitry, Frédérique Sablier-Gallis, Antoine Andremont, Lloyd Bod, François Ghiringhelli, Jean de Gunzburg, Bertrand Routy
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers. Nature communications 15 (1) (2024)
Loïs Coënon, Mannon Geindreau, François Ghiringhelli, Martín Villalba, Mélanie Bruchard
Natural Killer cells at the frontline in the fight against cancer. Cell death & disease 15 (8) (2024)
Nicolas Roussot, Julie Lecuelle, Lorraine Dalens, Caroline Truntzer, François Ghiringhelli
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report. Journal for immunotherapy of cancer 11 (10) (2023)
Lorraine Dalens, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Romain Boidot, Sandy Chevrier, Hugo Mananet, Valentin Derangère, Caroline Truntzer, François Ghiringhelli
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. International journal of molecular sciences 24 (8) (2023)
Julien Odet, Julie Pellegrinelli, Olivier Varbedian, Caroline Truntzer, Marco Midulla, François Ghiringhelli, David Orry
Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation. Journal of imaging 9 (3) (2023)
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Manon Reda, Juliette Albuisson, Laurent Arnould, Romain Boidot, Caroline Truntzer, François Ghiringhelli, Sylvain Ladoire
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer. Cancers 15 (4) (2023)
Julien Odet, Julie Pellegrinelli, Olivier Varbedian, Caroline Truntzer, Marco Midulla, François Ghiringhelli, David Orry
Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation. Journal of imaging 9 (3) (2023)
Lorraine Dalens, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Romain Boidot, Sandy Chevrier, Hugo Mananet, Valentin Derangère, Caroline Truntzer, François Ghiringhelli
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. International journal of molecular sciences 24 (8) (2023)
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Manon Reda, Juliette Albuisson, Laurent Arnould, Romain Boidot, Caroline Truntzer, François Ghiringhelli, Sylvain Ladoire
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer. Cancers 15 (4) (2023)
Julien Odet, Julie Pellegrinelli, Olivier Varbedian, Caroline Truntzer, Marco Midulla, François Ghiringhelli, David Orry
Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation. Journal of imaging 9 (3) (2023)
Julien Odet, Julie Pellegrinelli, Olivier Varbedian, Caroline Truntzer, Marco Midulla, François Ghiringhelli, David Orry
Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation. Journal of imaging 9 (3) (2023)
Guy Travis Clifton, Mace Rothenberg, Paolo Antonio Ascierto, Glenn Begley, Michael Cecchini, Joseph Paul Eder, François Ghiringhelli, Antoine Italiano, Marina Kochetkova, Rong Li, Fatima Mechta-Grigoriou, Sara I Pai, Paolo Provenzano, Ellen Puré, Antoni Ribas, Kurt A Schalper, Wolf Herman Fridman
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop. Journal for immunotherapy of cancer 11 (6) (2023)
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Fran Ois P Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine J Piccart
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nature communications 14 (1) (2023)
Marion Thibaudin, Jean-David Fumet, Benoist Chibaudel, Jaafar Bennouna, Christophe Borg, Jerome Martin-Babau, Romain Cohen, Marianne Fonck, Julien Taieb, Emeric Limagne, Julie Blanc, Elise Ballot, Léa Hampe, Marjorie Bon, Susy Daumoine, Morgane Peroz, Hugo Mananet, Valentin Derangère, Romain Boidot, Henri-Alexandre Michaud, Caroline Laheurte, Olivier Adotevi, Aurélie Bertaut, Caroline Truntzer, François Ghiringhelli
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial. Nature medicine (2023)
Nesrine Mabrouk, Cindy Racoeur, Jingxuan Shan, Aurélie Massot, Silvia Ghione, Malorie Privat, Lucile Dondaine, Elise Ballot, Caroline Truntzer, Romain Boidot, François Hermetet, Valentin Derangère, Mélanie Bruchard, Frédérique Végran, Lotfi Chouchane, François Ghiringhelli, Ali Bettaieb, Catherine Paul
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC. Cancers 15 (12) (2023)
Pauline Marolleau, David Tougeron, Benoit Allignet, Romain Cohen, David Sefrioui, Blandine Gallet, Frédéric Dumont, Rosine Guimbaud, Emily Alouani, Guillaume Passot, Grégoire Desolneux, François Ghiringhelli, Frédéric Marchal, Farouk Mourthadhoi, Romain Coriat, Romain Desgrippes, Christophe Locher, Gaël Goujon, Gaëtan Des Guetz, Thomas Aparicio, Etienne Paubelle, Aurélien Dupré, Christelle De La Fouchardière
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study. International journal of cancer (2023)
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Fran Ois P Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine J Piccart
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nature communications 14 (1) (2023)
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Manon Reda, Juliette Albuisson, Laurent Arnould, Romain Boidot, Caroline Truntzer, François Ghiringhelli, Sylvain Ladoire
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer. Cancers 15 (4) (2023)
Lorraine Dalens, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Romain Boidot, Sandy Chevrier, Hugo Mananet, Valentin Derangère, Caroline Truntzer, François Ghiringhelli
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. International journal of molecular sciences 24 (8) (2023)
Lorraine Dalens, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Romain Boidot, Sandy Chevrier, Hugo Mananet, Valentin Derangère, Caroline Truntzer, François Ghiringhelli
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. International journal of molecular sciences 24 (8) (2023)
Nesrine Mabrouk, Cindy Racoeur, Jingxuan Shan, Aurélie Massot, Silvia Ghione, Malorie Privat, Lucile Dondaine, Elise Ballot, Caroline Truntzer, Romain Boidot, François Hermetet, Valentin Derangère, Mélanie Bruchard, Frédérique Végran, Lotfi Chouchane, François Ghiringhelli, Ali Bettaieb, Catherine Paul
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC. Cancers 15 (12) (2023)
Valérie Jooste, Leila Bengrine-Lefevre, Sylvain Manfredi, Valérie Quipourt, Pascale Grosclaude, Olivier Facy, Côme Lepage, François Ghiringhelli, Anne Marie Bouvier
Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice. Cancers 14 (7) (2022)
Sylvain Ladoire, Cédric Rebe, François Ghiringhelli
Associating immunotherapy and targeted therapies: facts and hopes. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Nicolas Roussot, François Ghiringhelli, Cédric Rebe
Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment. Cells 11 (22) (2022)
Mélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, Caroline Truntzer, Elise Ballot, Romain Boidot, Cindy Racoeur, Emilie Barsac, Fanny Chalmin, Christophe Hibos, Thomas Baranek, Christophe Paget, Bernhard Ryffel, Cédric Rebe, Catherine Paul, Frédérique Végran, François Ghiringhelli
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nature immunology 23 (2) (2022)
Benjamin Tournier, Romain Aucagne, Caroline Truntzer, Cyril Fournier, François Ghiringhelli, Caroline Chapusot, Laurent Martin, Anne Marie Bouvier, Sylvain Manfredi, Valérie Jooste, Mary B Callanan, Côme Lepage
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers 15 (1) (2022)
Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, Valerio Iebba, Gérard Zalcman, Sylvie Friard, Julien Mazieres, Clarisse Audigier-Valette, Denis Moro-Sibilot, François Goldwasser, Carolina Alves Costa Silva, Safae Terrisse, Melodie Bonvalet, Arnaud Scherpereel, Hervé Pegliasco, Corentin Richard, François Ghiringhelli, Arielle Elkrief, Antoine Desilets, Felix Blanc-Durand, Fabio Cumbo, Aitor Blanco-Míguez, Romain Boidot, Sandy Chevrier, Romain Daillère, Guido Kroemer, Laurie Alla, Nicolas Pons, Emmanuelle Le Chatelier, Nathalie Galleron, Hugo Roume, Agathe Dubuisson, Nicole Bouchard, Meriem Messaoudene, Damien Drubay, Eric Deutsch, Fabrice Barlesi, David Planchard, Nicola Segata, Stéphanie Martinez, Laurence Zitvogel, Jean-Charles Soria, Benjamin Besse
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nature medicine 28 (2) (2022)
Benjamin Tournier, Romain Aucagne, Caroline Truntzer, Cyril Fournier, François Ghiringhelli, Caroline Chapusot, Laurent Martin, Anne Marie Bouvier, Sylvain Manfredi, Valérie Jooste, Mary B Callanan, Côme Lepage
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers 15 (1) (2022)
Trinh-Le-Vi Kieu, Léa Pierre, Valentin Derangère, Sabrina Perrey, Caroline Truntzer, Antoine Jalil, Sébastien Causse, Emma Groetz, Adélie Dumont, Laura Guyard, Laurent Arnould, Jean-Paul Pais de Barros, Lionel Apetoh, Cédric Rebe, Emeric Limagne, Tony Jourdan, Laurent Demizieux, David Masson, Charles Thomas, François Ghiringhelli, Mickaël Rialland
Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors. Cell death & disease 13 (9) (2022)
Benjamin Tournier, Romain Aucagne, Caroline Truntzer, Cyril Fournier, François Ghiringhelli, Caroline Chapusot, Laurent Martin, Anne Marie Bouvier, Sylvain Manfredi, Valérie Jooste, Mary B Callanan, Côme Lepage
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers 15 (1) (2022)
Romain Mary, Fanny Chalmin, Théo Accogli, Mélanie Bruchard, Christophe Hibos, Joséphine Melin, Caroline Truntzer, Emeric Limagne, Valentin Derangere, Marion Thibaudin, Etienne Humblin, Romain Boidot, Sandrine Chevrier, Laurent Arnould, Corentin Richard, Quentin Klopfenstein, Antoine Bernard, Yoshihiro Urade, James A Harker, Lionel Apetoh, François Ghiringhelli, Frédérique Végran
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects. Cancer immunology research 10 (7) (2022)
Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Coureche Kaderbhai, Romain Boidot, Sandy Chevrier, Philippe Joubert, Bertrand Routy, Caroline Truntzer, François Ghiringhelli
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer. Journal for immunotherapy of cancer 10 (3) (2022)
Laura Kalfeist, Loïck Galland, Fanny Ledys, François Ghiringhelli, Emeric Limagne, Sylvain Ladoire
Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells 11 (5) (2022)
Julie Niogret, Valentin Derangère, Corentin Richard, Lisa Nuttin, François Ghiringhelli, Laure Favier, Leila Bengrine Lefevre, Anthony Bergeron, Laurent Arnould, Romain Boidot
Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series. International journal of molecular sciences 23 (6) (2022)
Marc Ychou, Michel Rivoire, Simon Thezenas, Rosine Guimbaud, François Ghiringhelli, Anne Mercier-Blas, Laurent Mineur, Eric Francois, Faiza Khemissa, Marion Chauvenet, Reza Kianmanesh, Marianne Fonck, Philippe Houyau, Thomas Aparicio, Marie-Pierre Galais, Franck Audemar, Eric Assenat, Evelyne Lopez-Crapez, Claire Jouffroy, Antoine Adenis, René Adam, Olivier Bouché
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial. British journal of cancer 126 (9) (2022)
Hélène Bellio, Aurélie Bertaut, Alice Hervieu, Sylvie Zanetta, Audrey Hennequin, Julie Vincent, Rémi Palmier, Leila Bengrine-Lefevre, François Ghiringhelli, Jean-David Fumet
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer. Cancers 13 (21) (2021)
Paul Oster, Laurie Vaillant, Erika Riva, Brynn McMillan, Christina Begka, Caroline Truntzer, Corentin Richard, Marine M Leblond, Meriem Messaoudene, Elisavet Machremi, Emeric Limagne, François Ghiringhelli, Bertrand Routy, Gregory Verdeil, Dominique Velin
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut (2021)
Julie Pellegrinelli, Olivier Chevallier, Sylvain Manfredi, Inna Dygai-Cochet, Claire Tabouret-Viaud, Guillaume Nodari, François Ghiringhelli, Jean-Marc Riedinger, Romain Popoff, Jean-Marc Vrigneaud, Alexandre Cochet, Ludwig Serge Aho Glélé, Marianne Latournerie, Romaric Loffroy
Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience. Diagnostics (Basel, Switzerland) 11 (1) (2021)
Julie Niogret, Hélène Berger, Cédric Rebe, Romain Mary, Elise Ballot, Caroline Truntzer, Marion Thibaudin, Valentin Derangère, Christophe Hibos, Léa Hampe, David Rageot, Théo Accogli, Philippe Joubert, Bertrand Routy, James Harker, Frederique Vegran, François Ghiringhelli, Fanny Chalmin
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy. Journal for immunotherapy of cancer 9 (6) (2021)
Julie Lecuelle, Romain Boidot, Hugo Mananet, Valentin Derangère, Juliette Albuisson, Vincent Goussot, Laurent Arnould, Zoé Tharin, Isabelle L Ray-Coquard, François Ghiringhelli, Caroline Truntzer, Jean-David Fumet
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer. Cancers 13 (17) (2021)
Quentin Klopfenstein, Valentin Derangère, Laurent Arnould, Marion Thibaudin, Emeric Limagne, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire
Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer. Journal for immunotherapy of cancer 9 (6) (2021)
Melanie Bruchard, François Ghiringhelli
ILC2s in cancer: context matters. Nature immunology 22 (7) (2021)
Julie Lecuelle, Anne Aarnink, Zoé Tharin, Caroline Truntzer, François Ghiringhelli
Using Exome Sequencing to Improve Prediction of FOLFIRINOX First Efficacy for Pancreatic Adenocarcinoma. Cancers 13 (8) (2021)
Loïck Galland, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Caroline Truntzer, François Ghiringhelli
Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer. Cancers 13 (12) (2021)
Helene Bellio, Jean David Fumet, François Ghiringhelli
Targeting BRAF and RAS in Colorectal Cancer. Cancers 13 (9) (2021)
Juliette Palle, Laure Hirsch, Alexandra Lapeyre-Prost, David Malka, Morgane Bourhis, Simon Pernot, Elie Marcheteau, Thibault Voron, Florence Castan, Ariane Lacotte, Nadine Benhamouda, Corinne Tanchot, Eric François, François Ghiringhelli, Christelle De La Fouchardière, Aziz Zaanan, Eric Tartour, Gilles Manceau, Magali Terme
Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients. Cancers 13 (21) (2021)
Safae Terrisse, Lisa Derosa, Valerio Iebba, François Ghiringhelli, Ines Vaz-Luis, Guido Kroemer, Marine Fidelle, Stergios Christodoulidis, Nicola Segata, Andrew Maltez Thomas, Anne-Laure Martin, Aude Sirven, Sibille Everhard, Fanny Aprahamian, Nitharsshini Nirmalathasan, Romy Aarnoutse, Marjolein Smidt, Janine Ziemons, Carlos Caldas, Sibylle Loibl, Carsten Denkert, Sylvere Durand, Claudia Iglesias, Filippo Pietrantonio, Bertrand Routy, Fabrice André, Edoardo Pasolli, Suzette Delaloge, Laurence Zitvogel
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell death and differentiation 28 (9) (2021)
Olivier Chevallier, Ségolène Mvouama, Julie Pellegrinelli, Kévin Guillen, Sylvain Manfredi, François Ghiringhelli, Nicolas Falvo, Marco Midulla, Romaric Loffroy
Percutaneous Implantation of a Microcatheter-Port System for Hepatic Arterial Infusion Chemotherapy of Unresectable Liver Tumors: Technical Feasibility, Functionality, and Complications. Diagnostics (Basel, Switzerland) 11 (3) (2021)
Marine Dolat, Pauline Macaire, Françoise Goirand, Julie Vincent, Audrey Hennequin, Rémi Palmier, Leïla Bengrine-Lefevre, François Ghiringhelli, Bernard Royer, Antonin Schmitt
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Julie Niogret, Emeric Limagne, Marion Thibaudin, Julie Blanc, Aurelie Bertaut, Karine Le Malicot, Yves Rinaldi, François-Xavier Caroli-Bosc, Franck Audemar, Suzanne Nguyen, Corinne Sarda, Catherine Lombard-Bohas, Christophe Locher, Miguel Carreiro, Jean-Louis Legoux, Pierre-Luc Etienne, Mathieu Baconnier, Marc Porneuf, Thomas Aparicio, François Ghiringhelli
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma. Cancers 12 (6) (2020)
Jean-David Fumet, Emeric Limagne, Marion Thibaudin, François Ghiringhelli
Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy. Cancers 12 (9) (2020)
Jihane Boustani, Valentin Derangère, Aurélie Bertaut, Olivier Adotevi, Véronique Morgand, Céline Charon-Barra, François Ghiringhelli, Céline Mirjolet
Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer. Cells 9 (9) (2020)
Anaïs Perrichet, François Ghiringhelli, Cédric Rebe
Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency. Cancers 12 (12) (2020)
Elise Ballot, Sylvain Ladoire, Bertrand Routy, Caroline Truntzer, François Ghiringhelli
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy. Cancers 12 (9) (2020)
Anne Aarnink, Jean David Fumet, Laure Favier, Caroline Truntzer, François Ghiringhelli
Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France. Journal of cancer research and clinical oncology 146 (10) (2020)
Marion Picard, Satoru Yonekura, Karolina Slowicka, Ioanna Petta, Conrad Rauber, Bertrand Routy, Corentin Richard, Valerio Iebba, Maryam Tidjani Alou, Sonia Becharef, Pierre Ly, Eugenie Pizzato, Christian H K Lehmann, Lukas Amon, Christophe Klein, Paule Opolon, Ivo Gomperts Boneca, Jean-Yves Scoazec, Antoine Hollebecque, David Malka, François Ghiringhelli, Diana Dudziak, Geert Berx, Lars Vereecke, Geert van Loo, Guido Kroemer, Laurence Zitvogel, Maria Paula Roberti
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients. Cell death and differentiation 28 (5) (2020)
Cédric Rebe, François Ghiringhelli
Interleukin-1β and Cancer. Cancers 12 (7) (2020)
Lucie Demontoux, Valentin Derangère, Thomas Pilot, Chloé Thinselin, Angélique Chevriaux, Fanny Chalmin, Florence Bouyer, François Ghiringhelli, Cédric Rebe
Hypotonic stress enhances colon cancer cell death induced by platinum derivatives and immunologically improves antitumor efficacy of intraperitoneal chemotherapy. International journal of cancer 145 (11) (2019)
François Ghiringhelli, Julie Vincent, Leila Bengrine, Christophe Borg, Jean Louis Jouve, Romaric Loffroy, Boris Guiu, Julie Blanc, Aurélie Bertaut
Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study. Journal of cancer research and clinical oncology 145 (9) (2019)
Cynthia Reichling, Julien Taieb, Valentin Derangere, Quentin Klopfenstein, Karine Le Malicot, Jean-Marc Gornet, Hakim Becheur, Francis Fein, Oana Cojocarasu, Marie Christine Kaminsky, Jean Paul Lagasse, Dominique Luet, Suzanne Nguyen, Pierre-Luc Etienne, Mohamed Gasmi, Andre Vanoli, Hervé Perrier, Pierre-Laurent Puig, Jean-François Emile, Come Lepage, François Ghiringhelli
Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut 69 (4) (2019)